U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604480) titled 'Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational Study' on May 17.
Brief Summary: This prospective observational study evaluated the safety and efficacy of a remimazolam-propofol combination sedation protocol in adult patients undergoing elective gastrointestinal endoscopy at a tertiary care centre in Romania. The primary outcome was procedural completion. Secondary outcomes included time to sedation onset, recovery time, discharge readiness, total sedative doses administered, and incidence of adverse events including cardiovascular and respiratory complications.
Study Start Date:...